Professor Frédérique Penault-Llorca presents the challenges faced when assessing PD-L1 status. This includes:

• Acquiring a suitable sample

• Considerations of cytological assessment

• In a situation of borderline PD-L1 expression, quantifying this status and discussing its relevance

• Communicating this information to the oncology team

This presentation is a supporting resource for the Classroom to Clinic module “Biomarkers & predicting response to PD-1/PD-L1 inhibitors”.

Classroom to Clinic is a complete group learning package that allows you to build tailored CME-accredited meetings in minutes, and confidently deliver an effective meeting specific to the needs of your learners.

To explore Classroom to Clinic resources and more accredited CME, please visit Oncology Knowledge into Practice.

This independent educational activity is supported by an educational grant from Merck Sharp & Dohme Corp. The educational content has been developed by Liberum IME and validated by an independent steering committee; Merck Sharp & Dohme Corp has had no influence on the content of this education.